Crystalline form of 1-chloro-4-(ss-D-glucopyranos-1-yl)-2-[ 4-((s)-tetrahydrofuran-3-yloxy)-benzyl]- benzene, a method for its preparation and the use thereof for preparing medicaments
Details for Australian Patent Application No. 2006243859 (hide)
International Classifications
Event Publications
3 January 2008 PCT application entered the National Phase
PCT publication WO2006/117359 Priority application(s): WO2006/117359
29 September 2011 Application Accepted
Published as AU-B-2006243859
10 November 2011 Corrigenda
Applications Accepted - Name Index Under the name Boehringer Ingelheim International GmbH, Application No. 2006243859, under INID (72) correct the co-inventor to Schmid, Sandra
2 February 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006243868-4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroq uinoline derivatives the treatment of infertility
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser